Therapy Areas: Cardiovascular
27 September 2023 - Akebia Therapeutics, Inc. (Nasdaq: AKBA), a US-based, fully integrated biopharmaceutical company, announced on Tuesday that it has received approval from Australia's Therapeut...
20 September 2023 - AMO Pharma Limited, a UK-based privately held clinical-stage specialty biopharmaceutical company, announced on Tuesday its initial preclinical data from a study of the use of the c...
20 September 2023 - Purpose Life Sciences (PLS), a Canada-based specialty services research partner, announced on Tuesday that it has added Jeff Kindler and Calum MacRae, MD, PhD to the company's...
19 September 2023 - Caliway Biopharmaceuticals, a Taiwan-based biopharmaceutical company, announced on Monday that it has completed enrolment of subjects in the CBL-0201EFP Phase 2-stage 2 study.The s...
13 September 2023 - Primary Health Properties plc (LSE: PHP), a UK investor in modern primary healthcare facilities, announced on Wednesday that it has agreed to acquire Ireland's first Enhanced ...
12 September 2023 - Canadian life sciences firm Ondine Biomedical Inc (LON: OBI) announced on Tuesday that it has commenced an eight-month assessment of its Steriwave nasal photodisinfection technolog...